Clinical Trial Update: Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating two intravenous immunoglobulin regimens for newly diagnosed immune thrombocytopenia in children; the study is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: Fujian Medical University Union Hospital | Conditions: Newly Diagnosed Immune Thrombocytopenia in Children, First Line Treatment | Phase 4 | Status: RECRUITING